Giuliana Fortunato Selected Research

Giuliana Fortunato Research Topics

Disease

16	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2024 - 06/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2003
5	Hypercholesterolemia 04/2024 - 01/2019
4	Homozygous Familial Hypercholesterolemia 01/2024 - 01/2020
4	Atherosclerosis 04/2020 - 05/2007
3	Myocardial Infarction 04/2024 - 01/2023
3	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 01/2019
3	Cerebrotendinous Xanthomatosis 04/2021 - 10/2016
2	COVID-19 10/2022 - 06/2021
2	Genetic Risk Score 01/2022 - 01/2015
2	Hypertriglyceridemia 01/2022 - 09/2018
2	Pancreatitis 01/2022 - 09/2018
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 03/2008
2	Xanthomatosis (Xanthoma) 04/2020 - 10/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2020 - 01/2019
2	Dyslipidemias (Dyslipidemia) 04/2020 - 10/2016
1	Hypersensitivity (Allergy) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Heart Diseases (Heart Disease) 06/2021
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Lathosterolosis 12/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2019
1	Acute Disease 01/2019
1	Rare Diseases (Rare Disease) 09/2018
1	Vascular Diseases (Vascular Disease) 01/2017
1	Intellectual Disability (Idiocy) 10/2016
1	Diarrhea 10/2016
1	Cataract (Cataracts) 10/2016
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 02/2015
1	Mycoplasma Infections 01/2012
1	Ischemia 05/2011
1	Hypertension (High Blood Pressure) 05/2011
1	Colonic Neoplasms (Colon Cancer) 03/2010
1	Minicore Myopathy with External Ophthalmoplegia 04/2009
1	Malignant Hyperthermia 04/2009
1	Central Core Myopathy (Central Core Disease) 04/2009
1	Fibrosis (Cirrhosis) 02/2009
1	Chronic Hepatitis C 02/2009
1	Multiple Sclerosis 03/2008
1	Infections 03/2008
1	Inflammation (Inflammations) 05/2007
1	Noise-Induced Hearing Loss (Acoustic Trauma) 11/2004

Drug/Important Bio-Agent (IBA)

10	LDL CholesterolIBA 04/2024 - 01/2015
8	oxidized low density lipoproteinIBA 04/2024 - 01/2012
8	LipidsIBA 01/2024 - 10/2016
6	Aryldialkylphosphatase (Paraoxonase)IBA 04/2019 - 03/2003
5	CholesterolIBA 10/2020 - 05/2011
4	LDL Receptors (LDL Receptor)IBA 02/2023 - 06/2010
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2015
4	EnzymesIBA 04/2021 - 05/2007
3	Apolipoproteins B (ApoB)IBA 02/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2022
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 10/2020
2	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 04/2021 - 10/2016
2	Bile Acids and Salts (Bile Acids)IBA 04/2021 - 10/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021 - 10/2016
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 04/2019
2	Cholestanol (Coprostanol)IBA 12/2019 - 10/2016
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 01/2017
2	Proprotein Convertase 9IBA 11/2017 - 06/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 03/2010
2	Messenger RNA (mRNA)IBA 01/2012 - 03/2008
2	InterferonsIBA 02/2009 - 03/2008
1	omega-Chloroacetophenone (Mace)IBA 01/2024
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	pegaspargase (Oncaspar)FDA Link 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2021
1	pro-brain natriuretic peptide (1-76)IBA 06/2021
1	Natriuretic PeptidesIBA 06/2021
1	Troponin IIBA 06/2021
1	BMS201038IBA 01/2021
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 12/2020
1	SubtilisinIBA 10/2020
1	lathosterolIBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2019
1	AntioxidantsIBA 04/2019
1	Lipase (Acid Lipase)FDA Link 09/2018
1	ApolipoproteinsIBA 11/2017
1	SterolsIBA 10/2016
1	CyclinsIBA 01/2012
1	BM-cyclinIBA 01/2012
1	EnrofloxacinIBA 01/2012
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2012
1	HDL CholesterolIBA 05/2011
1	HDL LipoproteinsIBA 05/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2011
1	C-Reactive ProteinIBA 05/2011
1	Apolipoprotein B-100 (Apo B 100)IBA 06/2010
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 02/2009
1	HomocysteineIBA 02/2009
1	Superoxide DismutaseIBA 11/2004
1	Genetic Markers (Genetic Marker)IBA 03/2003

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2009
3	Percutaneous Coronary Intervention 04/2024 - 01/2023
1	Blood Component Removal (Apheresis) 01/2021
1	Carotid Endarterectomy 03/2008